Hamlin High Dividend Equity Fund;Inv
HHDVX
NASDAQ39.87
USD
+0.48
- -
Hamlin High Dividend Equity Fund;Inv
HHDVX
(NASDAQ)
Recent
price
39.87
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Hamlin High Dividend Equity Fund (HHDVX) is an open-end mutual fund that seeks high current income and long-term capital appreciation by investing at least 80% of its net assets in high dividend-yielding equity securities, primarily common stocks of large-cap U.S. companies, including real estate investment trusts (REITs); the fund maintains a concentrated portfolio of approximately 25 holdings with a weighted average dividend yield of 3.2%, median market capitalization of $63 billion, and sector allocations led by financials (18%), industrials (16%), consumer staples (13%), real estate (11%), and healthcare (10%). Top holdings include AbbVie Inc., CME Group Inc., Old Republic International Corp., Enterprise Products Partners L.P., and Public Service Enterprise Group Inc., with additional exposure to names such as Paychex Inc., Darden Restaurants Inc., Johnson & Johnson, Unilever PLC, and Procter & Gamble Co.; the Investor Class (HHDVX, CUSIP 00769G733) carries a net expense ratio of 1.15%, while the Institutional Class (HHDFX) offers 0.85%, both with no sales load and a minimum initial investment of $2,500 for Investor shares. Launched on March 30, 2012, and managed by Hamlin Capital Management, LLC, headquartered at 640 Fifth Avenue, 6th Floor, New York, with portfolio managers Christopher D'Agnes (since inception) and Michael Tang (since 2020), the fund operates primarily in U.S. markets with minor non-U.S. stock exposure (around 4%). Hamlin Capital Management, the fund's adviser founded in 2001, manages total firm assets exceeding $5 billion and emphasizes a low-volatility equity income strategy with a trailing 12-month beta of 0.66 relative to the S&P 500.